11/05/2024 | Press release | Distributed by Public on 11/05/2024 16:58
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||
|
1. Title of Derivate Security | 2. Date Exercisable and Expiration Date | 3. Title and Amount of Securities Underlying Derivative Security | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) | 6. Nature of Indirect Beneficial Ownership |
Date Exercisable | Expriation Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
ORBIMED ADVISORS LLC 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK, NY10022 |
X |
|
|
|
OrbiMed Capital GP VII LLC 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK, NY10022 |
X |
|
|
|
OrbiMed Capital GP VIII LLC 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK, NY10022 |
X |
|
|
|
OrbiMed Capital GP IX LLC 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK, NY10022 |
X |
|
|
|
/s/ Carl L. Gordon, Member of OrbiMed Advisors LLC | 2024-11-05 |
**Signature of Reporting Person | Date |
/s/ Carl L. Gordon, Member of OrbiMed Capital GP VII LLC | 2024-11-05 |
**Signature of Reporting Person | Date |
/s/ Carl L. Gordon, Member of OrbiMed Capital GP VIII LLC | 2024-11-05 |
**Signature of Reporting Person | Date |
/s/ Carl L. Gordon, Member of OrbiMed Capital GP IX LLC | 2024-11-05 |
**Signature of Reporting Person | Date |
(*) | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
(**) | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |